Supplier Enrollment Update and Continued Medical Need Reminder

Published in Member Communities on February 06, 2025

Ronda Buhrmester

Ronda Buhrmester, Sr. Director of Payer Relations and Reimbursement, shares updates on supplier enrollment and a reminder of continued medical need

Supplier Enrollment Update

For suppliers that have billing privileges with CMS using a supplier transaction number (PTAN), maintaining enrollment is of high priority. Any disruptions with not maintaining a PTAN cause havoc, including disruptions with cash flow from Medicare with the possibility of a domino effect to Medicaid and other payers. 

One of the key factors in maintaining a PTAN is updating the national provider enrollment (NPE) contractor of any changes. Common updates being submitted on the 855s/PECOS are related to a change to the business. Common changes include: 

  • Change in ownership 
  • Change of address 
  • Change in store hours 
  • Change in surety bond 
  • Change in services/products being offered 
  • Change in states of services being offered 

Recently, the NPE council met with the NPE contractor that provided an update on an issue. If a state is being added to the business’ territory where services are going to be offered or adding a new product, the update to the 855s cannot be submitted until the state license or certification requirements are met first. If the application is submitted without having the license or any certifications attached, this delays the update causing the application to not process until the license or any certifications are processed by the state.   

Basically, it will kick back to your company causing a resubmission all over again. 

Click here for more information

Continued Medical Need Reminder 

Once initial qualifications have been met for a DME item, ongoing medical need must be met. Depending on the type of item, such as supplies or equipment, the continued medical need can vary.   

Generally, for items such as CPAP supplies and home oxygen therapy, ongoing medical need can be justified with a valid standard written order (SWO) within the preceding 12 months.   

Oxygen therapy is unique because it’s considered a drug which is governed by the state’s Board of Pharmacy. For that reason, an annual order is required. 

For DME items such a hospital bed or standard wheelchair, the need is met with documentation in the medical record. This does not mean a visit is required with the treating practitioner. The treating practitioner can make a note in the patient’s chart documenting the medical need and benefits of use. 

For repairs to the equipment, the continued medical need can be completed with a valid SWO. 

Bottom line, it is important to know the policy requirements in addition to setting up the billing software to notify staff to maintain continued medical need requirements. 

Click here for more information


TAGS

  1. billing & reimbursement
  2. reimbursement
  3. vgm

From Our Experts

Simplify Your Reimbursement Process for the AffloVest thumbnail Simplify Your Reimbursement Process for the AffloVest To support clinicians, care teams, and payer partners, Tactile Medical has streamlined the process for determining medical necessity and documentation standards for the AffloVest. Matt Filippis Named Director of Business Development at VGM thumbnail Matt Filippis Named Director of Business Development at VGM VGM & Associates appoints Matt Filippis as Director of Business Development, Clinical Mobility and Accessibility, supporting CRT, home accessibility, and O&P providers. Matt Filippis Named Director of Business Development at VGM thumbnail Matt Filippis Named Director of Business Development at VGM VGM & Associates appoints Matt Filippis as Director of Business Development, Clinical Mobility and Accessibility, supporting CRT, home accessibility, and O&P providers. Simplify Your Reimbursement Process for the AffloVest thumbnail Simplify Your Reimbursement Process for the AffloVest To support clinicians, care teams, and payer partners, Tactile Medical has streamlined the process for determining medical necessity and documentation standards for the AffloVest. Matt Filippis Named Director of Business Development at VGM thumbnail Matt Filippis Named Director of Business Development at VGM VGM & Associates appoints Matt Filippis as Director of Business Development, Clinical Mobility and Accessibility, supporting CRT, home accessibility, and O&P providers. Matt Filippis Named Director of Business Development at VGM thumbnail Matt Filippis Named Director of Business Development at VGM VGM & Associates appoints Matt Filippis as Director of Business Development, Clinical Mobility and Accessibility, supporting CRT, home accessibility, and O&P providers. Alternative Sleep Therapies: Guidance for DME Providers thumbnail Alternative Sleep Therapies: Guidance for DME Providers Discover how oral appliance therapy, eXciteOSA, and other alternative sleep therapies are reshaping care in 2026. Alternative Sleep Therapies: Guidance for DME Providers thumbnail Alternative Sleep Therapies: Guidance for DME Providers Discover how oral appliance therapy, eXciteOSA, and other alternative sleep therapies are reshaping care in 2026.